In the MDA-MB-231 cell line, an ER (estrogen receptor)-negative cell line, EZH2 positively activated the transcription of NF-κB target genes in a methyltransferase-independent way, which contributed to aggressiveness of these breast cancer cells. The gene discussed is EZH2; the disease is breast carcinoma.